OpenVSafe by OpenVAERS
Search V-safe

5P8-28157-11327

2 vaccinations 1 coded response 6 check-ins 1 free-text entry 0 call cases
Sex
Male
Age at first dose
41-45
ZIP prefix
950 / CA
Registered
2021-02-12
Relationship
Self

Timeline

  1. 2021-01-15
    Dose 1 — Moderna
  2. 2021-02-12
    Registered in v-safe
  3. 2021-02-12
    Dose 2 — Moderna
  4. 2021-02-12
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches
    Adult check-in
  5. 2021-02-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Arthralgia, Chills, Decreased appetite, Feeling cold, Headache, Injection site pain, Myalgia, Pain — Feeling: Fair · Site: Pain, Swelling · Muscle or body aches
    Free text: These two surveys arent quite timed well enough to capture symptoms; the first survey at 10hrs my symptoms were only developing..second survey at 36hrs I am starting to feel better; HOWEVER 12-18hrs AFTER ADMINISTRATION OF SECOND DOSE WAS SEVERE SYMPTOMS OF PAIN, FULL BODY MUSCLE/JOINT PAINS, CHILLS, HEADACHE, LOSS OF APPETITE, however no nausea, no breathing problems..symptoms at 8-10hrs were mild and I was able to function,HOWEVER 12-18hrs Was SEVERE AND INTENSE INJECTION SITE PAIN AND FULL BODY ACHES, UNCOMFORTABLE TO WALK/BEAR WEIGHT, AND UNABLE TO EAT, UNABLE TO GET WARM DESPITE FULLY CLOTHED AND UNDER COVERS/BEDSPREAD WITH STOCKING CAP ON. Second day at 36hrs I am sore but able to do normal daily activities
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-02-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  7. 2021-02-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  8. 2021-02-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-02-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-15Moderna
22021-02-12Moderna

Free text

Release 4 — days 1–6 daily, dose 2

2021-02-13

Systemic reaction (other): These two surveys arent quite timed well enough to capture symptoms; the first survey at 10hrs my symptoms were only developing..second survey at 36hrs I am starting to feel better; HOWEVER 12-18hrs AFTER ADMINISTRATION OF SECOND DOSE WAS SEVERE SYMPTOMS OF PAIN, FULL BODY MUSCLE/JOINT PAINS, CHILLS, HEADACHE, LOSS OF APPETITE, however no nausea, no breathing problems..symptoms at 8-10hrs were mild and I was able to function,HOWEVER 12-18hrs Was SEVERE AND INTENSE INJECTION SITE PAIN AND FULL BODY ACHES, UNCOMFORTABLE TO WALK/BEAR WEIGHT, AND UNABLE TO EAT, UNABLE TO GET WARM DESPITE FULLY CLOTHED AND UNDER COVERS/BEDSPREAD WITH STOCKING CAP ON. Second day at 36hrs I am sore but able to do normal daily activities

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROArthralgia ✓ ✓ ✓
SROChills ✓ ✓ ✓
SRODecreased appetite ✓ ✓ ✓
SROFeeling cold ✓ ✓ ✓
SROHeadache ✓ ✓ ✓
SROInjection site pain ✓ ✓ ✓
SROMyalgia ✓ ✓ ✓
SROPain ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release